Investors
CENTERLINE BIOMEDICAL OVERVIEW
About
Centerline Biomedical is a Cleveland Clinic spinoff company commercializing the Intra-Operative Positioning System (IOPS™) technology — an innovative, 3D GPS-like surgical navigation technology that improves endovascular procedure outcomes and reduces radiation exposure.
HISTORY
Founded at Cleveland Clinic following the vision of renowned vascular surgeon, Roy Greenberg, MD
PROBLEM
Radiation emitting, 2D grayscale fluoroscopy has remained mainly unchanged decades
SOLUTION
IOPS™ (Intra-Operative Positioning System) 3D surgical navigation platform technology
TEAM
Well experienced leadership team averaging 20+ years in healthcare
ADVISORY BOARD
Scientific advisory board: Matthew Eagleton, MD (Mass General), Robert Beasley, MD (Mt. Siai), Mark Farber, MD (UNC Hospitals), Gustavo Oderich, MD (UTHealth & Memorial Hermann), Federicon Ezequiel Parodi, MD (UNC Hospitals), Rishi Puri, MD (Cleveland Clinic), Peter Rasmussen, MD, FAHA, FAANS, FSNIS (Cleveland Clinic), Karl West, MS (Cleveland Clinic)
HIGHLIGHTS
FDA Cleared
510(k) approved in a large market ($3.1B) for procedures in the descending aorta
R&D Pipeline
– Structural Heart (TAVR, TP, TMVR)
– Peripheral Vascular Disease
– Vascular Surgery
Intellectual Property
Rich and growing IP portfolio with 17 issued and 37 pending patents
Strategic Partnerships
Two signed, two in advanced stages. Broad range of partnership opportunities.
Clinical
First in Human procedures completed
GeoEx
Expanding to Europe & beyond in 2021
Commercial
Controlled launch ongoing
Grants
Recipient of 4 NIH Grants
CONTACT & LEARN MORE